World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
80
Citations
35169
World Ranking
1598
National Ranking
797

Michael C. Jensen publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Michael C. Jensen sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 330 publications — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Michael C. Jensen D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Michael C. Jensen sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 80 D-Index — 68th percentile

68% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Michael C. Jensen is affiliated with Seattle Children's Hospital in the United States. Their research primarily focuses on medicine, with a strong emphasis on oncology, immunology, genetics, molecular biology, and biomedical engineering.

The main topics of Michael C. Jensen's work include:

  • CAR-T cell therapy research
  • Nanowire synthesis and applications
  • Immunotherapy and immune responses
  • Glioma diagnosis and treatment
  • Virus-based gene therapy research
  • Advancements in semiconductor devices and circuit design
  • Immune cell function and interaction

Frequent publication venues for their work are:

  • Neuro-Oncology
  • Journal of Clinical Oncology
  • Cancer Research
  • Blood
  • bioRxiv (Cold Spring Harbor Laboratory)

Michael C. Jensen has collaborated often with the following researchers:

  • Rebecca Gardner
  • Ashley Wilson
  • Julie R. Park
  • Nicholas A. Vitanza
  • Kristy Seidel

Notable recent papers include:

  • Intracerebroventricular B7-H3-targeting CAR T cells for diffuse intrinsic pontine glioma: a phase 1 trial, 2025, Nature Medicine
  • Intraventricular B7-H3 CAR T Cells for Diffuse Intrinsic Pontine Glioma: Preliminary First-in-Human Bioactivity and Safety, 2022, Cancer Discovery
  • Off-the-shelf, steroid-resistant, IL13Rα2-specific CAR T cells for treatment of glioblastoma, 2022, Neuro-Oncology
  • Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysis, 2021, Nature Medicine
  • Genetically engineered macrophages persist in solid tumors and locally deliver therapeutic proteins to activate immune responses, 2020, Journal for ImmunoTherapy of Cancer

Their body of work comprises over 100 publications in medicine, predominantly in oncology and immunology subfields. This reflects an interdisciplinary approach integrating molecular biology and biomedical engineering principles to advance treatment strategies, particularly in CAR-T cell therapies and glioma.

Best Publications

  • Current concepts in the diagnosis and management of cytokine release syndrome

    Daniel W. Lee;Rebecca Gardner;David L. Porter;Chrystal U. Louis

  • CD19 CAR–T cells of defined CD4+:CD8+ composition in adult B cell ALL patients

    Cameron J. Turtle;Laïla Aïcha Hanafi;Carolina Berger;Theodore A. Gooley

  • Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy

    Brown Ce;Alizadeh D;Starr R;Weng L

  • Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma

    Andrew T Parsa;James S Waldron;Amith Panner;Courtney A Crane

  • Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults.

    Rebecca A. Gardner;Rebecca A. Gardner;Olivia Finney;Colleen Annesley;Colleen Annesley;Hannah Brakke

  • Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells.

    Brian G. Till;Brian G. Till;Michael C. Jensen;Jinjuan Wang;Eric Y. Chen

  • Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates.

    Carolina Berger;Michael C. Jensen;Peter M. Lansdorp;Mike Gough

  • Adoptive transfer of chimeric antigen receptor re-directed cytolytic T lymphocyte clones in patients with neuroblastoma.

    Julie R. Park;David L. DiGiusto;Marilyn Slovak;Christine Wright

  • A transgene encoded cell surface polypeptide for selection, in vivo tracking, and ablation of engineered cells

    Xiuli Wang;Wen Chung Chang;ChingLam W. Wong;David Colcher

  • Acquisition of a CD19-negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T-cell therapy

    Rebecca Gardner;David Wu;Sindhu Cherian;Min Fang

  • CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results.

    Brian G. Till;Brian G. Till;Michael C. Jensen;Michael C. Jensen;Jinjuan Wang;Xiaojun Qian

  • CD28 Costimulation Provided through a CD19-Specific Chimeric Antigen Receptor Enhances In vivo Persistence and Antitumor Efficacy of Adoptively Transferred T Cells

    Claudia M. Kowolik;Max S. Topp;Sergio Gonzalez;Timothy Pfeiffer

  • Antitransgene Rejection Responses Contribute to Attenuated Persistence of Adoptively Transferred CD20/CD19-Specific Chimeric Antigen Receptor Redirected T Cells in Humans

    Michael C. Jensen;Leslie Popplewell;Laurence J. Cooper;David DiGiusto

  • Receptor Affinity and Extracellular Domain Modifications Affect Tumor Recognition by ROR1-Specific Chimeric Antigen Receptor T Cells

    Michael Hudecek;Maria Teresa Lupo-Stanghellini;Paula L. Kosasih;Daniel Sommermeyer

  • T Cells Expressing CD19/CD20 Bispecific Chimeric Antigen Receptors Prevent Antigen Escape by Malignant B Cells

    Eugenia Zah;Meng-Yin Lin;Anne Silva-Benedict;Michael C. Jensen

  • The Nonsignaling Extracellular Spacer Domain of Chimeric Antigen Receptors Is Decisive for In Vivo Antitumor Activity

    Michael Hudecek;Michael Hudecek;Daniel Sommermeyer;Paula L. Kosasih;Anne Silva-Benedict;Anne Silva-Benedict

  • T cells expressing CD123-specific chimeric antigen receptors exhibit specific cytolytic effector functions and antitumor effects against human acute myeloid leukemia

    Armen Mardiros;Cedric Dos Santos;Tinisha McDonald;Christine E. Brown

  • CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity

    Elad Jacoby;Sang M. Nguyen;Thomas J. Fountaine;Kathryn Welp

  • Specific Recognition and Killing of Glioblastoma Multiforme by Interleukin 13-Zetakine Redirected Cytolytic T Cells

    Kanwarpal S. Kahlon;Christine Brown;Laurence J. N. Cooper;Andrew Raubitschek

  • Noninvasive detection of therapeutic cytolytic T cells with 18F-FHBG PET in a patient with glioma.

    Shahriar S Yaghoubi;Michael C Jensen;Nagichettiar Satyamurthy;Shradha Budhiraja

  • Safety and immunologic effects of IL-15 administration in nonhuman primates.

    S. Carolina Berger;Michael Berger;Robert C. Hackman;Robert C. Hackman;Michael Gough

Frequent Co-Authors

Stanley R. Riddell
Stanley R. Riddell University of Washington
Stephen J. Forman
Stephen J. Forman City Of Hope National Medical Center
Laurence J.N. Cooper
Laurence J.N. Cooper The University of Texas MD Anderson Cancer Center
Philip D. Greenberg
Philip D. Greenberg Fred Hutchinson Cancer Research Center
Oliver W. Press
Oliver W. Press University of Washington
David G. Maloney
David G. Maloney Fred Hutchinson Cancer Research Center
Christine E. Brown
Christine E. Brown City Of Hope National Medical Center
Cameron J. Turtle
Cameron J. Turtle Fred Hutchinson Cancer Research Center
Brent L. Wood
Brent L. Wood University of Washington
Philip D. Gregory
Philip D. Gregory Sangamo BioSciences (United States)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying immunology opens doors to numerous health and science careers, many of which benefit from complementary healthcare degrees. For those interested in entering the healthcare field quickly, programs like the easiest absn program to get into offer accelerated paths to becoming a registered nurse, providing valuable clinical experience related to immune system health.

Similarly, if your goal is to begin your nursing career with practical skills, considering the best easiest lpn programs to get into can be a strategic step. Licensed Practical Nurses often work alongside immunologists in clinical settings, gaining foundational medical knowledge.

For those aiming for advanced practice and specialized care, exploring the easiest nurse practitioner degree programs helps identify accessible routes to these roles. Nurse practitioners frequently engage with immunology-related conditions, enhancing their scope of patient care.

Additionally, mental health intersects with immunology in many ways, making programs like the top psychiatric mental health nurse practitioner programs online highly relevant. These programs prepare professionals to address complex health issues involving the immune and nervous systems.

Best Scientists Citing Michael C. Jensen

Trending Scientists

Recently Published Articles